What is the recommended treatment for an adult with an acute asthma exacerbation?

Treatment of Acute Asthma Exacerbation in Adults

Immediately administer three simultaneous therapies without delay: high-dose inhaled short-acting β₂-agonist (albuterol 2.5–5 mg nebulized or 4–8 puffs via MDI with spacer every 20 minutes for three doses), systemic corticosteroids (prednisolone 40–60 mg orally or hydrocortisone 200 mg IV), and supplemental oxygen to maintain SpO₂ >90%. 1, 2

Initial Assessment (First 5–15 Minutes)

Obtain objective measurements immediately:

• Measure peak expiratory flow (PEF) or FEV₁ before treatment—failure to obtain objective measurements is the most common preventable cause of asthma death 2
• Assess respiratory rate, heart rate, ability to speak full sentences, oxygen saturation, and mental status 1, 2

Severity classification:

• Severe exacerbation: inability to complete sentences in one breath, respiratory rate >25/min, heart rate >110/min, PEF <50% predicted 1, 2
• Life-threatening: PEF <33% predicted, silent chest, cyanosis, feeble respiratory effort, altered mental status, bradycardia or hypotension, PaCO₂ ≥42 mmHg in a dyspneic patient 1, 2

High-risk features requiring heightened vigilance:

• Prior intubation or ICU admission for asthma 2
• ≥2 hospitalizations or ≥3 ED visits in the past year 2
• Use of >2 short-acting β₂-agonist canisters per month 2
• Recent hospitalization or ED visit within the past month 2
• Poor perception of symptom severity 2

First-Hour Treatment Protocol

Bronchodilator Therapy

• Albuterol: 2.5–5 mg via oxygen-driven nebulizer OR 4–8 puffs from MDI with spacer every 20 minutes for three consecutive doses 1, 2
• Add ipratropium bromide: 0.5 mg to each nebulized treatment (or 8 puffs via MDI) for all moderate-to-severe exacerbations—this combination reduces hospitalization risk 1, 2
• Continue ipratropium for the first three doses only; it provides no additional benefit once the patient is hospitalized 1

Systemic Corticosteroids (Must Be Given Immediately)

• Adults: prednisolone 40–60 mg orally OR IV hydrocortisone 200 mg 1, 2
• Oral administration is as effective as IV and is strongly preferred when tolerated 2
• Never delay corticosteroids while "trying bronchodilators first"—clinical benefit requires 6–12 hours, making early delivery critical 2

Oxygen Therapy

• Deliver 40–60% oxygen via face mask or nasal cannula to maintain SpO₂ >90% (target >95% in pregnant patients or those with cardiac disease) 1, 2
• Oxygen does not worsen CO₂ retention in asthma 2

Reassessment at 15–30 Minutes

Re-measure PEF/FEV₁ and reassess symptoms, vital signs, and oxygen saturation to guide next steps 2

Good Response (PEF >75% Predicted)

• Step up usual maintenance therapy with modest increase in inhaled corticosteroids 2
• Monitor symptoms and PEF on a chart 2
• Arrange follow-up within 48 hours 2

Incomplete Response (PEF 50–75% Predicted)

• Continue nebulized β₂-agonist every 4–6 hours 2
• Maintain oral corticosteroids 2
• Consider hospital admission if severe features persist 2

Poor Response (PEF <50% Predicted or Persistent Severe Features)

• Increase nebulized β₂-agonist frequency to every 15–30 minutes 2
• Continue ipratropium bromide 0.5 mg every 20 minutes for additional doses 2
• Arrange immediate hospital admission 2

Escalation for Refractory Cases (After 1 Hour of Intensive Therapy)

Intravenous Magnesium Sulfate

• Administer 2 g IV over 20 minutes for severe exacerbations with PEF <40% after initial treatment or any life-threatening feature 2
• This reduces hospitalization risk in severe cases 2

Intravenous Aminophylline

• Consider 250 mg IV over 20 minutes for life-threatening features unresponsive to initial measures 2
• Never give bolus aminophylline to patients already receiving oral theophylline due to toxicity risk 2

Continuous Nebulized Albuterol

• May be considered for markedly severe cases: 10–15 mg/hour continuously 1
• Use large-volume nebulizers for continuous administration 1

Hospital Admission Criteria

Admit immediately for:

• Any life-threatening feature (PEF <33%, silent chest, altered mental status, PaCO₂ ≥42 mmHg) 2
• Severe attack features persisting after initial therapy 2
• PEF <50% predicted after 1–2 hours of intensive treatment 2

Lower threshold for admission when:

• Presentation occurs in the evening or overnight 2
• Recent nocturnal or worsening symptoms 2
• Prior intubation or ≥2 hospitalizations or ≥3 ED visits in the past year 2
• Poor social circumstances limiting reliable monitoring 2

ICU Transfer Criteria

Transfer to intensive care when:

• Deteriorating PEF despite ongoing therapy 2
• Worsening or persistent hypoxia/hypercapnia 2
• Exhaustion, feeble respirations, or altered mental status 2
• Coma or respiratory arrest 2
• A physician prepared to intubate is needed 2

Critical Pitfalls to Avoid

• Never administer sedatives of any kind—they are absolutely contraindicated and potentially fatal 2
• Do not rely solely on subjective assessment; objective PEF/FEV₁ measurement is mandatory 2
• Do not delay corticosteroids while attempting bronchodilator therapy alone 2
• Do not underestimate severity; clinicians frequently fail to recognize dangerous exacerbations 2
• Routine antibiotics are not recommended unless bacterial infection is documented 2

Discharge Planning (After Stabilization)

Discharge criteria:

• PEF ≥70–75% of predicted or personal best 2
• Symptoms minimal or absent 2
• Oxygen saturation stable on room air 2
• Patient remains stable for 30–60 minutes after last bronchodilator dose 2

Prior to discharge:

• Continue oral corticosteroids for 5–10 days (no taper needed for courses <10 days) 2
• Initiate or continue inhaled corticosteroids 2
• Verify and document correct inhaler technique 2
• Provide written asthma action plan with PEF zones 2
• Supply peak flow meter 2
• Arrange primary-care follow-up within 1 week 2
• Arrange specialist follow-up within 4 weeks 2